Octreotide acetate in prevention of chemoradiation-induced diarrhea in anorectal cancer: randomized RTOG trial 0315 (Q33803090)

29 July 2017

Octreotide acetate in prevention of chemoradiation-induced diarrhea in anorectal cancer: randomized RTOG trial 0315 (English)

1 reference

29 July 2017

0 references

0 references

4

Jaffer Ajani

1 reference

29 July 2017

Babu Zachariah

1

1 reference

29 July 2017

Clement K Gwede

2

1 reference

29 July 2017

Jennifer James

3

1 reference

29 July 2017

Lisa J Chin

5

1 reference

29 July 2017

David Donath

6

1 reference

29 July 2017

Seth A Rosenthal

7

1 reference

29 July 2017

Brent L Kane

8

1 reference

29 July 2017

Marvin Rotman

9

1 reference

29 July 2017

Lawrence Berk

10

1 reference

29 July 2017

Lisa A Kachnic

11

1 reference

29 July 2017

language of work or name

English

0 references

publication date

25 March 2010

1 reference

Journal of the National Cancer Institute

29 July 2017

1 reference

29 July 2017

102

1 reference

29 July 2017

8

1 reference

29 July 2017

547-556

1 reference

NRG Oncology Radiation Therapy Oncology Group 0822: A Phase 2 Study of Preoperative Chemoradiation Therapy Using Intensity Modulated Radiation Therapy in Combination With Capecitabine and Oxaliplatin for Patients With Locally Advanced Rectal Cancer

29 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857801

Radiation Therapy Oncology Group 0247: a randomized Phase II study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857801

Phase III, double-blind study of depot octreotide versus placebo in the prevention of acute diarrhea in patients receiving pelvic radiation therapy: results of North Central Cancer Treatment Group N00CA

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857801

Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857801

Prevention and management of chemotherapy-induced diarrhea in patients with colorectal cancer: a consensus statement by the Canadian Working Group on Chemotherapy-Induced Diarrhea

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857801

Octreotide long-acting formulation (LAR) in chronic loperamide-refractory diarrhea not related to cancer treatment.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857801

The bootstrap: a technique for data-driven statistics. Using computer-intensive analyses to explore experimental data

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857801

Staging of colorectal cancer: past, present, and future

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857801

Preoperative versus postoperative chemoradiotherapy for rectal cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857801

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857801

Development of a head and neck companion module for the quality of life-radiation therapy instrument (QOL-RTI)

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857801

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857801

Acute treatment-related diarrhea during postoperative adjuvant therapy for high-risk rectal carcinoma.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857801

The randomization and stratification of patients to clinical trials

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857801

The use of the long-acting somatostatin analogue, octreotide acetate, in patients with islet cell tumors

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857801

Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control--final report of intergroup 0114.

28 July 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ063

Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ063

The long-term effect of adjuvant postoperative chemoradiotherapy for rectal carcinoma on bowel function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ063

Resolution of refractory chemotherapy-induced diarrhea (CID) with octreotide long-acting formulation in cancer patients: 11 case studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ063

Octreotide LAR resolves severe chemotherapy-induced diarrhoea (CID) and allows continuation of full-dose therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ063

A pilot study of patient quality of life during radiation therapy treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ063

Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ063

Patient assessment of bowel function during and after pelvic radiotherapy: results of a prospective phase III North Central Cancer Treatment Group clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ063

The efficacy of octreotide in the therapy of acute radiation-induced diarrhea: a randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ063

A multicenter, randomized trial of long-acting octreotide for the optimum prevention of chemotherapy-induced diarrhea: results of the STOP trial

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857801

Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2857801

Phase III Study of Pentosanpolysulfate (PPS) in Treatment of Gastrointestinal Tract Sequelae of Radiotherapy

30 October 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJQ063

Epidermoid carcinoma of the anal canal. A series of 276 cases

21 January 2018

1 reference

12 December 2020

Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02

1 reference

12 December 2020

Control of chemotherapy-induced diarrhea with octreotide. A randomized trial with placebo in patients receiving cisplatin

1 reference

12 December 2020

Effects of short-time somatostatin infusion on the gastric and intestinal propulsion in humans

1 reference

12 December 2020

Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and

1 reference

12 December 2020

Radiation therapy in the conservative management of cancers of the low rectum and anal canal

1 reference

12 December 2020

Subcutaneous octreotide versus oral loperamide in the treatment of diarrhea following chemotherapy

1 reference

12 December 2020

Long-term anorectal dysfunction after postoperative radiotherapy for rectal cancer

1 reference

12 December 2020

Preoperative irradiation affects functional results after surgery for rectal cancer: results from a randomized study

1 reference

12 December 2020

Sucralfate in the prevention of treatment-induced diarrhea in patients receiving pelvic radiation therapy: A North Central Cancer Treatment Group phase III double-blind placebo-controlled trial

1 reference

12 December 2020

Preliminary results of preoperative 5-fluorouracil, low-dose leucovorin, and concurrent radiation therapy for clinically resectable T3 rectal cancer

1 reference

12 December 2020

Treatment of epidermoid anal canal cancer

1 reference

12 December 2020

Effect of somatostatin on diarrhea and on small intestinal water and electrolyte transport in a patient with pancreatic cholera

1 reference

12 December 2020

Sphincter-sparing treatment for distal rectal adenocarcinoma

1 reference

12 December 2020

Octreotide versus loperamide in the treatment of fluorouracil-induced diarrhea: a randomized trial

1 reference

12 December 2020

Identifiers

DOI

10.1093/JNCI/DJQ063

1 reference

29 July 2017

1 reference

29 July 2017

1 reference